NEW YORK, NY–(Marketwired – Aug 10, 2016) – DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCQB: DIGP), an independent cannabis lab testing and media firm, is pleased to announce it has been selected as the laboratory testing service provider for Green Therapeutics (GT), a licensed cannabis cultivator and producer with facilities located in North Las Vegas and Clark County, Nevada.

GT is the exclusive Nevada licensee of Moxie Seeds & Extracts, one of the leading cannabis extract producers in the United States with over 50 cannabis cup wins. Moxie produces a variety of extracts, including waxes, shatters, oils, hashes, and tinctures, as well as sells seeds for a range of cannabis strains.

Mike Tulimero, Operations Manager at Moxie, said, “We looked at all of the testing labs in Las Vegas and concluded that DigiPath Labs had the most to offer. They have a great staff of scientists, deliver results in only 48 hours, and their customer service is second to none.”

DigiPath Labs’ state-of-the-art Las Vegas laboratory was developed to elevate the standard for cannabis testing. The team carefully selected equipment and verified standard operating procedures to ensure reliable, replicable results. DigiPath is honored to have been chosen as the laboratory-testing provider for such a well-renowned brand.

Todd Denkin, President of DigiPath, commented, “Moxie is very popular in California and we are excited to be testing this brand as it is introduced to the Nevada market. They have built a strong working relationship with the local group at Green Therapeutics, and we look forward to help keeping them safe.”